# OnCo record nct06136650 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06136650/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06136650", "NCT06136650" ;
  schema:name "A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)"@en ;
  schema:alternateName "OMAHA-004"@en ;
  schema:description "A phase 3 trial testing Opevesostat in prostate cancer, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06136650/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06136650> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "3" ;
  schema:startDate "2023-12-18" ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/prostate-mcrpc/> ;
  onco:drugs <https://onco.cc/drugs/opevesostat/> ;
  onco:companies <https://onco.cc/companies/merck/> .